This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover the importance of investing for long-term goals and how it can help you achieve financial independence. Start your investment journey.
28,293 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
A fresh analysis connects men’s decisions to leave work with what they see during childhood about wages and unemploym...
Chemours faces a year of nuanced cycles in pigments and fluorochemicals. This guide breaks down what to watch in chem...
Investors are debating the right holding period for XRP to maximize returns. New market patterns show patience throug...
A veteran market commentator shines a light on a legacy chipmaker as a serious AI play. This analysis weighs the case...
Nike stock has fallen significantly from its 52-week peak, even as the CEO buys shares. This guide explains what the ...
June inflation cooled, sparking a rally in crypto markets. Ethereum led the way with a double‑digit gain, while Bitco...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
Amazon plans an unprecedented AI data-center buildout, with a $200 billion capex target for 2026. This article unpack...
UiPath edges higher as investors monitor its agentic automation strategy ahead of earnings. This analysis breaks down...
February brought a sharp pullback for Robinhood, driven by crypto swings and a broader shift in its business model. T...